India, Sept. 23 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:1. Moxonidine 200 microgram Tablets2. Moxonidine 400 microgram Tablets
Published by HT Digital Content Services with permission from Pivotal Sources....